Printed from https://fyi.org.nz/request/3536-management-of-dexamfetamine-supply?unfold=1 on April 20, 2024 18:28

Management of Dexamfetamine supply

Anita Easton made this Official Information request to Pharmaceutical Management Agency

The request was partially successful.

From: Anita Easton

Dear Pharmaceutical Management Agency,

Please note that this request should be considered separately from my urgent request for an update on dexamfetamine supply. Completion of the response to this request should not delay your response to my urgent request.

Can you please provide all information you hold on the current supply management issue for dexamfetamine. I am interested in the cause, management, mitigation and resolution of the issue.

This request includes, but is not limited to:
1) Any discussions, analysis, explanations or other information about the cause of the current non supply.
2) Any briefings to any other agencies or Ministers on the current supply issues.
3) All advice provided to doctors, pharmacists, pharmaceutical wholesalers, their professional organisations or any other medical professionals on the supply issues, guidance on alternatives, and their role in managing it.
4) Any discussions, analysis, briefings or other information about decisions made to seek to source an alternative medication.
5) Any discussions, analysis, explanations or other information about Pharmac's management of the current supply issue.
6) All correspondence with the supplier, or their representatives or agents or related parties, about the resolution to the issue, the cause of the issue, and approaches to mitigating the impact of the issue.

In addition, could you provide summary information on any previous supply issues with dexamfetamine.

Yours faithfully,

Anita Easton

Link to this

From: Web Enquiry
Pharmaceutical Management Agency

Thank you for your email. We are looking into your query and will get back
to you as quickly as possible. Please note, our response time may vary
depending on the nature of your request.

Link to this

From: Web Enquiry
Pharmaceutical Management Agency

Dear Anita

This email is to acknowledge that your request for information under the Official Information Act (1982) has been received and is currently being worked on.

We will have a reply to you as soon as possible and no later than the due date of 15 February 2016.

Kind regards,

Alexis Poppelbaum
PHARMAC

-----Original Message-----
From: Anita Easton [mailto:[OIA #3536 email]]
Sent: Monday, 11 January 2016 9:29 p.m.
To: Web Enquiry
Subject: Official Information Act request - Management of Dexamfetamine supply

Dear Pharmaceutical Management Agency,

Please note that this request should be considered separately from my urgent request for an update on dexamfetamine supply. Completion of the response to this request should not delay your response to my urgent request.

Can you please provide all information you hold on the current supply management issue for dexamfetamine. I am interested in the cause, management, mitigation and resolution of the issue.

This request includes, but is not limited to:
1) Any discussions, analysis, explanations or other information about the cause of the current non supply.
2) Any briefings to any other agencies or Ministers on the current supply issues.
3) All advice provided to doctors, pharmacists, pharmaceutical wholesalers, their professional organisations or any other medical professionals on the supply issues, guidance on alternatives, and their role in managing it.
4) Any discussions, analysis, briefings or other information about decisions made to seek to source an alternative medication.
5) Any discussions, analysis, explanations or other information about Pharmac's management of the current supply issue.
6) All correspondence with the supplier, or their representatives or agents or related parties, about the resolution to the issue, the cause of the issue, and approaches to mitigating the impact of the issue.

In addition, could you provide summary information on any previous supply issues with dexamfetamine.

Yours faithfully,

Anita Easton

-------------------------------------------------------------------

This is an OIA request done via the FYI website.

Please do not send progress updates as PDF files.

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers

If you find this service useful as an OIA officer, please ask your web manager to link to us from your organisation's OIA page.

-------------------------------------------------------------------

**********************************************************************
This email and any files transmitted with it are confidential and
intended solely for the use of the individual or entity to whom they
are addressed. If you have received this email in error please notify
the system manager.

This footnote also confirms that this email message has been swept by
MIMEsweeper for the presence of computer viruses.

www.clearswift.com
**********************************************************************

hide quoted sections

Link to this

From: Web Enquiry
Pharmaceutical Management Agency

Attachment Response to 2016 01 11 Anita Easton Management of Dexamfetamine supply.pdf
79K Download View as HTML

Attachment Dexamfetamine documents for release.pdf
682K Download View as HTML

Dear Anita

 

Please find attached PHARMAC’s response to your recent OIA request.

 

Kind regards

Victoria London

PHARMAC

 

 

 

**********************************************************************

This email and any files transmitted with it are confidential and

intended solely for the use of the individual or entity to whom they

are addressed. If you have received this email in error please notify

the system manager.

This footnote also confirms that this email message has been swept by

MIMEsweeper for the presence of computer viruses.

www.clearswift.com

**********************************************************************

hide quoted sections

Link to this

From: Anita Easton

Dear Victoria,

Thank you for you response. I appreciate the partial response given the extension you have needed.

For clarity I would like to state that the lack of supply issue I am requesting information about lasted until mid January 2016 (an earlier response from Pharmac said 13 January, in Wellington it was until 18 January).

The documentation you released in your partial response talked about an anticipated out of stock until mid December. I am assuming that this out of stock continued until mid January - that was our impression when trying to get prescriptions filled - and that your response will cover the entire issue.

If they were, in fact, two different issues I would like to extend my request to cover the second supply issue.

Thanks!!

Anita Easton

Link to this

From: Web Enquiry
Pharmaceutical Management Agency

Attachment Anita Easton Dexamphetamine OIA Final response.pdf
75K Download View as HTML

Attachment Documents for release Anita Easton OIA.pdf
31.5M Download View as HTML

Dear Anita

 

Please find attached PHARMAC’s response to your recent OIA request.

 

Kind regards

Victoria London

PHARMAC

 

**********************************************************************

This email and any files transmitted with it are confidential and

intended solely for the use of the individual or entity to whom they

are addressed. If you have received this email in error please notify

the system manager.

This footnote also confirms that this email message has been swept by

MIMEsweeper for the presence of computer viruses.

www.clearswift.com

**********************************************************************

hide quoted sections

Link to this

Things to do with this request

Anyone:
Pharmaceutical Management Agency only: